We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Image-Guided Biopsy of Bone Tumors

By HospiMedica staff writers
Posted on 04 Jun 2002
An easier and faster alternative to open surgical biopsy for patients who have a bone tumor is a needle biopsy closely guided by an imaging procedure, either computed tomography (CT) or fluoroscopy, according to a study published in the June 2002 issue of Radiology.

The study showed that percutaneous biopsy, in most cases guided by CT, performed on 110 patients with primary bone tumors provided a correct tissue diagnosis in 88% of the patients, which is comparable to open surgery biopsy results. More...
The procedure correctly identified tumors as malignant or benign in all but two cases, for a 98% accuracy rate, also the same as for surgical biopsy. Complications were limited to a single small blood clot at the biopsy site. No blood vessels or nerves were injured.

Open surgical biopsy requires a general anesthetic and an incision that can take up to 10 days to heal and leaves a two-to-five inch scar. No tumor therapy is recommended for two weeks. In contrast, needle biopsy can be performed immediately in the outpatient department. Instead of anesthesia, the patient receives a combination of intravenous sedation and local anesthetic. The procedure takes less than an hour and the anesthesia wears off within two hours. Specimens may be taken from different parts of the tumor. Also, because it is less invasive, treatment can begin immediately. In addition, needle biopsy can be three times more cost effective.

"The single most outstanding attribute of this method is that a patient can have a biopsy the same day he or she sees the orthopedic oncologist about a tumor,” said James S. Jelinek, M.D., of the Washington Cancer Institute at Washington Hospital Center (DC, USA; www.whcenter.org) and lead author. The study was published in the June 2002 issue of Radiology.




Related Links:
Washington Hospital

Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gas Analyzer
GE SAM
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.